Embargoed until 00:01 GMT Monday 22 November 2010
The Innovative Vector Control Consortium (IVCC) has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and other insects which transmit malaria, dengue and other neglected tropical diseases.
IVCC was established in 2005 with an initial grant of $50.7 million over five years from the foundation. Since then, an unprecedented development pipeline of new, reformulated and repurposed insecticides has been established in partnership projects with leading global chemical companies. A suite of information systems and diagnostic tools for the more effective and efficient use of insecticides has also been developed, with these products now nearing the end of their development phase and being readied for rollout in the coming year.
The new five year grant will support new and ongoing projects to develop new Active Ingredients for insecticides and to complete the existing portfolio of insecticide formulation and repurposing projects.
Chief Executive Officer Professor Janet Hemingway explained: “The need for new insecticides has never been greater. Increased funding for control programmes is saving thousands of lives but malaria is still killing one child in Africa every 45 seconds. Resistance to insecticides is increasing at an alarming rate and we must find new alternatives even if we are to stay still in our battle against this and other vector borne diseases.
“This award allows us continue the pioneering work we’re doing in partnership with the chemical industry to find and develop totally new classes of insecticide to help put an end to this needless loss of life. Our strategic aim is to provide three new Active Ingredients for use in public health insecticides by 2020.”
For further information, please contact:
IVCC Communications Manager
Notes for Editors
The IVCC is a Product Development Partnership (PDP) established as a not for profit company and registered charity to overcome the barriers to innovation in the development of new insecticides for public health vector control and to develop information systems and tools which will enable new and existing pesticides to be used more effectively.
Vector control is a cornerstone of effective campaigns to control diseases such as malaria and dengue, but effective interventions are increasingly under threat from the emergence and spread of insecticide resistance and limitations in the ways that insecticides are used.
IVCC has demonstrated that the PDP business model has been effective in unlocking the latent enthusiasm of the global pest control industry in the development of new public health insecticides. An unprecedented pipeline of new product development programmes to find insecticides which will be unaffected by current resistance mechanisms is emerging as a result.